(Q34271496)

English

A randomized, placebo-controlled phase I study assessing the safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein OprF/I vaccine (IC43) in healthy volunteers

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

A randomized, placebo-controlled phase I study assessing the safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein OprF/I vaccine (IC43) in healthy volunteers (English)

1 reference

Europe PubMed Central

1 August 2017

0 references

membrane protein

1 reference

based on heuristic

inferred from title

Pseudomonas aeruginosa

1 reference

based on heuristic

inferred from title

6

object named as

Bernd Jilma

1 reference

Europe PubMed Central

1 August 2017

Michael Schwameis

5

object named as

Michael Schwameis

1 reference

Europe PubMed Central

1 August 2017

author name string

Kerstin Westritschnig

1

1 reference

Europe PubMed Central

1 August 2017

Romana Hochreiter

2

1 reference

Europe PubMed Central

1 August 2017

Gerhard Wallner

3

1 reference

Europe PubMed Central

1 August 2017

Christa Firbas

4

1 reference

Europe PubMed Central

1 August 2017

publication date

24 September 2013

1 reference

Europe PubMed Central

1 August 2017

Human Vaccines & Immunotherapeutics

1 reference

Europe PubMed Central

1 August 2017

10

1 reference

Europe PubMed Central

1 August 2017

1

1 reference

Europe PubMed Central

1 August 2017

170-183

1 reference

Europe PubMed Central

1 August 2017

Pseudomonas infection in chronic obstructive pulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4181012

6 July 2018

Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4181012

6 July 2018

Systemic, nasal and oral live vaccines against Pseudomonas aeruginosa: a clinical trial of immunogenicity in lower airways of human volunteers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4181012

6 July 2018

Safety and immunogenicity of inactivated, Vero cell culture-derived whole virus influenza A/H5N1 vaccine given alone or with aluminum hydroxide adjuvant in healthy adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4181012

6 July 2018

Pseudomonas aeruginosa: a formidable and ever-present adversary

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4181012

6 July 2018

Kinetics and longevity of antibody response to influenza A H5N1 virus infection in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4181012

6 July 2018

Vaccine adjuvants: the dream becomes real

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4181012

6 July 2018

ClpXP proteases positively regulate alginate overexpression and mucoid conversion in Pseudomonas aeruginosa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4181012

6 July 2018

A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4181012

6 July 2018

Safety and immunogenicity of an oral inactivated whole-cell pseudomonas aeruginosa vaccine administered to healthy human subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4181012

6 July 2018

Application of vaccine technology to prevention of Pseudomonas aeruginosa infections.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4181012

6 July 2018

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4181012

6 July 2018

Safety and immunogenicity of an intranasal Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4181012

6 July 2018

Safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4181012

6 July 2018

Safety and immunogenicity of a Pseudomonas aeruginosa outer membrane protein I vaccine in human volunteers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4181012

6 July 2018

Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins for persons with altered immunocompetence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4181012

6 July 2018

Risk factors for infection by Pseudomonas aeruginosa in patients with ventilator-associated pneumonia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4181012

6 July 2018

Surface localization of Pseudomonas aeruginosa outer membrane porin protein F by using monoclonal antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4181012

6 July 2018

Controlled trials of a polyvalent pseudomonas vaccine in burns

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4181012

6 July 2018

Population-based study of the epidemiology and the risk factors for Pseudomonas aeruginosa bloodstream infection

1 reference

https://api.crossref.org/works/10.4161%2FHV.26565

21 January 2018

Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia

1 reference

https://api.crossref.org/works/10.4161%2FHV.26565

21 January 2018

Clinical study to assess the immunogenicity and safety of a recombinant Pseudomonas aeruginosa OprF-OprI vaccine in burn patients

1 reference

https://api.crossref.org/works/10.4161%2FHV.26565

21 January 2018

Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system

1 reference

https://api.crossref.org/works/10.4161%2FHV.26565

21 January 2018

Immunogenicity, safety and lot consistency in adults of a chromatographically purified Vero-cell rabies vaccine: a randomized, double-blind trial with human diploid cell rabies vaccine

1 reference

https://api.crossref.org/works/10.4161%2FHV.26565

21 January 2018

Human immune response to a Pseudomonas aeruginosa outer membrane protein vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/24064511

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rabipur: a reliable vaccine for rabies protection

1 reference

https://pubmed.ncbi.nlm.nih.gov/24064511

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of two immunization schedules for a Pseudomonas aeruginosa outer membrane proteins vaccine in burn patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24064511

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of Parenteral Colistin for the Treatment of Serious Infection Due to Antimicrobial-Resistant Pseudomonas aeruginosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/24064511

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The abbreviated 2-1-1 schedule of purified chick embryo cell rabies vaccination for rabies postexposure treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/24064511

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.4161/HV.26565

1 reference

Europe PubMed Central

1 August 2017

PMC publication ID

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34271496&oldid=1957077916"